TNFSF10 and diabetes mellitus: In NOD mice that received STZ as a diabetes-accelerating agent, TRAIL expression displayed a statistically significant yet temporary decrease between the second and fourth days of injection, when at least two out of three mice sacrificed were diabetes free (P < 0.05) (Figure 3(b)).